Parkinson

Credit: S. El Aidy, University of Groningen Patients with Parkinson's disease are treated with levodopa, which is converted into dopamine, a neurotransmitter in the brain. In a study published on 18 January in the journal Nature…
Read More...

EAST LANSING, Mich. - A Michigan State University study is the first to show an association between unusually high pesticide exposure and poor sense of smell among aging farmers. The research examined more than 11,200 farmers over a…
Read More...

New study suggests an important role for glial cells in Parkinson's disease and offers potential new therapeutic targets.Credit: IDIBELL A team of scientists led by Prof. Antonella Consiglio from the IDIBELL and the University of…
Read More...

Credit: Michigan State University EAST LANSING, Mich. -- A Michigan State University researcher has received a $2.8 million federal grant to develop a gene therapy that could reduce and possibly eliminate a frustrating side effect of a…
Read More...

Life Biosciences LLC leads strategic investment of up to A$44.5 million (US$31.4 million) in Prana MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA - 28 December 2018: Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) ("Prana" or "the…
Read More...

Leuven researchers led by professor Bart De Strooper (VIB-KU Leuven) have identified a new role for PARL, a protein that has been linked to Parkinson's disease. In this week's edition of the Proceedings of the National Academy of Science,…
Read More...

Device fine-tunes treatment by stimulating and and recording electric current in the brain at the same timeCredit: Rikky Muller, UC Berkeley A new neurostimulator developed by engineers at the University of California, Berkeley, can listen…
Read More...

The article by Dr. Alireza Mohammadi et al. is published in Current Gene Therapy, Volume 18, Issue 4, 2018 Parkinson's disease is a neurodegenerative disorder characterized by motor and nonmotor deficits majorly caused by the loss of…
Read More...

Scientists have taken a key step towards improving an emerging class of treatments for Parkinson's disease. The advance could markedly improve a next generation of therapies for the condition, which affects around one in 350 people…
Read More...

Issued in conjunction with the Michael J. Fox Foundation, important consensus guidelines for running proof of concept preclinical and clinical trials of drugs targeting alpha-synuclein to slow or arrest the progression of the diseaseCredit:…
Read More...

Australian researchers have discovered how a protein linked to Parkinson's disease may protect cells such as neurons in the brainCredit: The Walter and Eliza Hall Institute Australian researchers have discovered how a protein linked to…
Read More...

Salk scientist receives $300,000 for study of how brain learns and memorizes actions, processes which can go awry in diseases such as Parkinson's and OCDCredit: Salk Institute LA JOLLA--(December 14, 2018) Xin Jin, an associate professor…
Read More...

This article by Dr. Manoli Igartua et al. is published in Current Drug Delivery, Volume 15, Issue 9, 2018 Nanomedicine refers to field of science that uses nanotechnology for clinical operations. The use of nanoparticles (NPs) has…
Read More...

Known as a reward that makes us seek pleasure, dopamine also reinforces avoidance of painCredit: Christine Liu graphic For decades, psychologists have viewed the neurotransmitter dopamine as a double-edged sword: released in the brain as…
Read More...